Pilot Study of tSCS for Improving Upper Limb Function in People With Multiple Sclerosis
Launched by PARC DE SALUT MAR ·
Trial Information
Current as of October 17, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people with multiple sclerosis (MS) improve the movement and strength of their arms and hands. The study uses a device called SCONE™ that sends gentle, non-invasive electrical signals to the spinal cord, combined with special exercises for the upper limbs. The goal is to see if this combination can make it easier for people with MS to use their arms and hands better, and to check if the treatment is safe and comfortable.
People with MS who are interested in improving their upper limb function might be eligible to join, regardless of gender. While the exact age range isn’t specified clearly, the study is open to adults who meet the health requirements. Participants will receive the SCONE™ therapy along with guided rehabilitation exercises focused on their arms and hands. This study is not yet recruiting, but it offers a promising approach to support people with MS in gaining better arm and hand movement through a non-invasive treatment.
Gender
ALL
Eligibility criteria
About Parc De Salut Mar
Parc de Salut Mar is a leading healthcare institution located in Barcelona, Spain, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a prominent sponsor, it focuses on a wide range of therapeutic areas, emphasizing collaboration between multidisciplinary teams of healthcare professionals and researchers. The institution is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing to the development of cutting-edge treatments and therapies. With state-of-the-art facilities and a strong emphasis on patient-centered care, Parc de Salut Mar plays a vital role in the evolving landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported